LIVING WITH IT WORKING WITH IT TREATING IT
Management of allergic and chronic pulmonary aspergillosis masterclass by Prof David Denning, presented at AAA conference in Istanbul january 2012. Part 1 Radiological and clinical presentation & diagnosis.
The first Aspergillosis for Patients Meeting was held in Rome on Feb 3rd, 2010 and is now available for viewing as both videos and slides.
A summary of the potential health impacts of living in a damp home: Video provided by US companies with a financial interest in remediating homes so some marketing of specific services is featured.
A collection of video and audio resources intended for patients consisting of self help, patients own stories and patient conference talks.
A patient interview. This patient RW- with long term chronic pulmonary aspergillosis describes his experiences over 18 years during which he has taken various antifungal treatments. He remains well and currently takes itraconazole.
Video interview with patient with an aspergilloma and chronic pulmonary aspergillosis, diagnosed after coughing up blood who later developed azole resistance on voriconazole.
Video Interview with long-term ABPA patient who coughed up large sputum plugs. This patient had several episodes of pneumonia and developed bronchiectasis after diagnosis for a collapsed left lung.
Video interview with patient with childhood asthma and ABPA, who showed a marked improvement in her ABPA and asthma when she commenced nebulised Amphotericin B.
Video interview with this patient with childhood asthma and ABPA. After persistent chest infections and continuous steroids and a bad productive cough, Aspergillus was cultured from sputum in 2002.
Video interview with patient JW with childhood asthma and subsequent ABPA, describes his experience with 3 different azole types of antifungal drugs and who showed a marked improvement when taking posaconazole.
Video interview with Catherine who following a kidney transplant developed severe invasive aspergillosis, but was successfully treated with antifungal drugs.